Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

LAAO significantly lowers the risk of stroke after surgery among heart rhythm patients

“This is a procedure that’s done once, and it keeps giving a benefit over time,” one researcher said. “This is going to prevent thousands of strokes.”

FDA announces recall of more than 60,000 Abbott pacemakers due to risk of electrical short

The FDA has received complaints about 135 injuries so far. 

Thumbnail

Significant MR after TAVR linked to higher mortality rates—but staged interventions may help

Percutaneous edge-to-edge mitral valve repair was associated with improved outcomes among TAVR patients with persistent mitral regurgitation. 

Thumbnail

FDA advisory: Magnets in cell phones, smart watches can affect implanted medical devices

Though this does not seem to be a significant issue, the agency still recommends keeping consumer electronics at least six inches away from implanted medical devices.

Thumbnail

Young heart attack survivors who battle depression, anxiety more likely to have subsequent CV complications

“Our findings suggest that cardiologists should consider the value of regular psychological assessments, especially among younger patients,” one researcher said. The team's full findings will be presented at ACC.21. 

High blood pressure linked to greater risk of heart failure, AFib, heart attack, stroke

The authors evaluated data from more than 2.1 million patients, sharing their findings in Circulation.

Thumbnail

FDA announces new recall of instructions for Medtronic’s HVAD system after 1 death, 64 injuries

This Class I recall covers more than 130,000 different devices, according to the FDA. 

CDC recommends COVID-19 vaccines for teens

The Centers for Diseases Control and Prevention has voted to recommend the Pfizer-BioNTech Covid-19 vaccine to children between 12 and 15, though a handful of states already lowered age restrictions on vaccines ahead of the vote.